Shearman & Sterling is advising Symphony Technology Group in its acquisition of Source Healthcare Analytics from Wolters Kluwer N.V. The financial terms of the transaction were not disclosed.

Symphony Technology Group will combine Source Healthcare Analytics with its existing portfolio company, ImpactRx, Inc., to form a new company called Symphony Health Solutions Corporation, which will be focused on delivering high-value data, analytics, and technology-based solutions for clients across life science manufacturers, payers and providers.

Symphony Technology Group is a strategic private equity firm with the mission of investing in and building great software, data and technology-enabled services companies.  Symphony’s current portfolio consists of 13 global companies. Source Healthcare Analytics, LLC is a leader in comprehensive patient and physician-level prescription and usage data to the pharmaceutical industry. Wolters Kluwer N.V. is a market-leading global information services and publishing company focused on professionals. STG ImpactRx, Inc. is a leader in measuring the impact of promotion on physician prescribing behavior.

The Shearman & Sterling team included Bay Area M&A partners Steve Camahort (San Francisco-Mergers & Acquisitions) and Dana Kromm (San Francisco-Mergers & Acquisitions) and associate Joshua Reynolds (San Francisco-Mergers & Acquisitions), along with partners Steve Sherman(New York-Finance), Larry Crouch (Palo Alto-Tax), and Samuel Waxman(New York-Intellectual Property Transactions); counsel Eileen O’Pray (Palo Alto-Tax); and associates Dan Stellenberg (Palo Alto-Executive Compensation & Employee Benefits), Nathan Wood (Palo Alto-Finance), Zheng Bao (Palo Alto-Intellectual Property Transactions), Jin Wang (Beijing-Intellectual Property Transactions), Michael Jokic (New York-Intellectual Property Transactions), Gary Tashjian (New York-Executive Compensation & Employee Benefits) and Jung Yoo (New York-Intellectual Property Transactions).


Related Posts:

Leave a Reply